Bölüm "MACVIA-France, Contre les MAladies Chroniques Pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France; INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France; UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France; Kyomed, Montpellier, France; Faculdade de Medicina, Center for Health Technology and Services Research- CINTESIS, Universidade do Porto, Porto, Portugal; Allergy Unit, CUF Porto Instituto & Hospital, Porto, Portugal; Allergy Center, CUF-Descobertas Hospital, Lisboa, Portugal; Faculty of Medicine, Imunoalergologia, Centro Hospitalar Universitário de Coimbra, University of Coimbra, Coimbra, Portugal; EPAR U707 INSERM, Paris and EPAR UMR-S UPMC, Paris VI, Paris, France; UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, CHRU de Montpellier, Sorbonne Universités, Paris, France; Laboratoire de Pharmacologie Respiratoire UPRES EA220, Pôle des Maladies Respiratoires, Hôpital Foch, Université Versailles Saint-Quentin, Suresnes, France; INSERM, IAB, U 1209, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Université Joseph Fourier, Université Grenoble Alpes, Grenoble, France; CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, Naples, Italy; Personalized Medicine Clinic Asthma & Allergy, Humanitas Research Hospital, Humanitas University, Milan, Italy; Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, Salerno, Italy; Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy; ProAR – Nucleo de Excelencia em Asma, Brasil and GARD Executive Committee, Federal University of Bahia, Salvador, Brazil; Asthma Reference Center, Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria, Vitória, Brazil; Allergy Service, University Hospital of Federal University of Santa Catarina (HU-UFSC), Florianopolis, Brazil; Center of Excellence in Asthma and Allergy, Hospital Médica Sur, México, Mexico; Pediatric Allergy and Clinical Immunology, Hospital Angeles Pedregal, Mexico City, Mexico; Centro Médico Zambrano Hellion, Monterrey, Mexico; Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany; Global Allergy and Asthma European Network (GA ² LEN) , Berlin, Germany; Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany; Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany; Center for Rhinology and Allergology, Wiesbaden, Germany; Medical Faculty, Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany; iQ4U Consultants Ltd, London, United Kingdom; Observational and Pragmatic Research Institute, Singapore, Singapore; Optimum Patient Care, Cambridge, United Kingdom; Academic Centre of Primary Care, University of Aberdeen, Aberdeen, United Kingdom; Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom; Asthma UK Centre for Applied Research, Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, United Kingdom; Centre for Research in Environmental Epidemiology (CREAL), ISGLoBAL, Barcelona, Spain; IMIM (Hospital del Mar Research Institute), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP) & Universitat Pompeu Fabra (UPF), Barcelona, Spain; Pneumology and Allergy Department Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain; Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland; Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, Netherlands; Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland; Department of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark; Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW, Australia; Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia; Department of Immunology, Monash University, Melbourne, VIC, Australia; Department of ENT, Medical University of Graz, Graz, Austria; Department of Pulmonology, Celal Bayar University, Manisa, Turkey; GARD Executive Committee, Manisa, Turkey; Cerrahpasa Faculty of Medicine, Department of Pulmonary Diseases, Istanbul University, Istanbul, Turkey; Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium; Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden; Sachs’ Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Peercode DV, Gerdermalsen, Netherlands; Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Poland" için listeleme